DAFTAR PUSTAKA

Achiwa Y., Hasegawa K., Komiya T., and Udagawa Y., 2005, Ursolic Acid

Induces Bax-dependent Apoptosis through the Caspase-3 Pathway in

Endometrial CancerSNG-II Cells, Oncol Rep., 13:51–7.

Alberts, B., Johnson, A., Lewis, J., Raff, M., Robert, K., and Walter, P., 2008,

Chapter 18 Apoptosis : Programmed Cell Death Eliminates Unwanted

Cells, Molecular Biology of the Cell 5th Ed., Garland Science, p.1115.

Alison, M.R., 2004, The Cancer Handbook, John Wiley & Sons, Ltd., New York.

Almagro, M.C., and Vucic, D., 2012, The inhibitor of apoptosis (IAP) proteins are

critical regulators of signaling pathways and targets for anti-cancer

therapy, Experimental oncology, 34(3):200-211.

Altieri, D.C., 2006, Validating survivin as a cancer therapeutic target, Nature

Review Cancer, 3:46-54.

American Cancer Society, 2014, Colorectal Cancer Facts and Figures 2014-2016, American Cancer
Society, NW, Atlanta.

Andriyani, R., Risdian, C., and Udin, Z., 2011, Cytotoxicity Assay From

Fractions of Hedyotis corymbosa Extract Against Breast Cancer Cell

Line T47D, IJCC, 2(1):182-186.

Arifin, I., 2013, Efek Sinergistik Asam Ursolat terhadap Aktivitas Sitotoksik

Doksorubisin pada Sel Kanker Payudara MCF-7, Tesis, Universitas

Gadjah Mada, Yogyakarta, Indonesia.

ATCC, 2013, Cell Biology, WiDr (ATCC®CCL-218TM), ATCC Collection,

diakses tanggal 15 Agustus 2014,

<http://www.atcc.org/ATCCAdvancedCatalogSearch/Products/All/CCL-218.aspx>.

Backer, C.A.,Bakhuizen, and Van Den Brink, R.C., 1965, Flora of Java

(Spermatophites only) vol II N.V., NordhoffGroningen, The Nederlands,

274-288.

Baldwin, A.S., 2001, Control of oncogenesis and cancer therapy resistance by the

transcription factor NF-κB, Journal of Clinical Investigations, 107:241-246.

Blagosklonny, M.V., Robey, R., Bates, S., and Fojo, T., 2000, Pretreatment with

DNA-damaging agents permits selective killing of checkpoint-deficient

cells by microtubule-active drugs, J. Clin. Invest., 105(4):533-539.

Bounmendjel, A., Boutonnant, J., and Robert, J., 2009, ABC Transporters and

Multidrug Resistance, John Wiley & Sons, Inc., New Jersey, USA.